Clincosm LogoSign in Get a demo

obstructive hypertrophic cardiomyopathy

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mavacamten in Korean Symptomatic Obstructive Hypertrophic

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Nov 23, 2023

Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Beijing, China
  • +9 more
Oct 31, 2023

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Charlottesville, Virginia
    University of Virginia
Aug 28, 2023

Obstructive Hypertrophic Cardiomyopathy Trial (HRS-1893, Placebo)

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • (no location specified)
May 18, 2023

Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • pace maker implant guided by acute hemodynamic testing
  • Milan, Italy
    Istituto Auxologico Italiano
Mar 6, 2023

Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive

Completed
  • Septal Hypertrophy
  • Obstructive Hypertrophic Cardiomyopathy
  • Cryo myectomy
  • Myectomy
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 3, 2023

Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy Trial in

Active, not recruiting
  • Hypertrophic Cardiomyopathy
  • +2 more
  • Scottsdale, Arizona
  • +68 more
Sep 20, 2022

Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
    • (no location specified)
    Aug 3, 2022

    Patients' Long-Term Survival of Obstructive Hypertrophic

    Completed
    • Cardiomyopathy
    • Obstructive Hypertrophic Cardiomyopathy
      • Bethesda, Maryland
        National Heart, Lung and Blood Institute (NHLBI)
      May 27, 2022

      Obstructive Hypertrophic Cardiomyopathy Trial in Beijing (Mavacamten, Placebo)

      Recruiting
      • Obstructive Hypertrophic Cardiomyopathy
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jan 17, 2022

      Obstructive Hypertrophic Cardiomyopathy Trial in Worldwide (mavacamten, Placebo)

      Completed
      Has Results
      • Obstructive Hypertrophic Cardiomyopathy
      • Scottsdale, Arizona
      • +70 more
      Sep 7, 2021

      Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects Trial in Beijing (CK-3773274, Placebo)

      Completed
      • Obstructive Hypertrophic Cardiomyopathy
      • Healthy Adult Subjects
      • Beijing, Beijing, China
        Clinical Site
      Sep 12, 2021

      Non-obstructive Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy Trial in Sao Paulo (CPAP)

      Completed
      • Non-obstructive Hypertrophic Cardiomyopathy
      • Obstructive Hypertrophic Cardiomyopathy
      • CPAP
      • Sao Paulo, Brazil
        Heart Institute
      Dec 18, 2014